Back to Search
HAROLD DVORAK, M.D.
M.D.
Anatomic Pathology Physician
NPI: 1306951454Individual
Specialties, Licenses & Credentials
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
28286(MA)
Research & Publications (20)
Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma.
PMID 12759232·Am J Pathol·2003
7-preclinical
Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.
PMID 12409337·J Clin Oncol·2002
6-review
Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase.
PMID 19443844·Arterioscler Thromb Vasc Biol·2009
4-observational
VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation.
PMID 19435903·Cancer Res·2009
7-preclinical
Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level.
PMID 19528255·FASEB J·2009
7-preclinical
The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis.
PMID 19351819·Cancer Res·2009
7-preclinical
Why are tumour blood vessels abnormal and why is it important to know?
PMID 19240721·Br J Cancer·2009
6-review
Chapter 3. The adenoviral vector angiogenesis/lymphangiogenesis assay.
PMID 19007660·Methods Enzymol·2008
7-preclinical
Vascular permeability, vascular hyperpermeability and angiogenesis.
PMID 18293091·Angiogenesis·2008
6-review
Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.
PMID 17535974·J Exp Med·2007
4-observational
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.
PMID 16904613·Cancer Cell·2006
7-preclinical
Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity.
PMID 16520388·J Exp Med·2006
7-preclinical
Permeability properties of tumor surrogate blood vessels induced by VEGF-A.
PMID 16732297·Lab Invest·2006
7-preclinical
Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
PMID 17114339·Mol Cancer Res·2006
7-preclinical
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin.
PMID 15766663·Cancer Cell·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- BETH ISRAEL DEACONESS MEDICAL CENTER, 330 BROOKLINE AVENUE
BOSTON, MA 02215 - Phone
- (617) 667-4343
Quick Facts
- NPI
- 1306951454
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile